Document Detail


Elevated circulating free fatty acids levels causing pancreatic islet cell dysfunction through oxidative stress.
MedLine Citation:
PMID:  19915385     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Elevated plasma free fatty acids (FFA) concentration is predictive of the conversion from normal glucose tolerance and impaired glucose tolerance to diabetes. AIMS: To evaluate the effects of prolonged exposure to FFA on basal and glucose-stimulated insulin secretion (GSIS) of pancreatic beta-cell, and to investigate the role of oxidative stress in FFA-induced decrease in beta-cell function. METHODS: Rats were assigned to 3 groups and underwent 96-h infusions of normal saline (NS), intralipid plus heparin (IH), or intralipid plus heparin and N-acetylcysteine (IH+NAC). The plasma insulin, malonyldialdehyde (MDA), reduced glutathione (GSH), and oxidized glutathione (GSSG) were measured. In vivo intravenous glucose tolerance test (IVGTT) and ex vivo isolated pancreatic tissues perfusion were performed. RESULTS: In IH group GSIS both in IVGTT and perifused pancreatic tissues were impaired (p<0.05), the GSH/GSSG ratio was declined and MDA levels increased (p<0.05), the volume density score of nuclear factor kappaB and inducible nitric oxide synthase in pancreatic islets were increased compared to the NS group (p<0.01). In IH+NAC group, NAC intervention partly restored the GSH/GSSG ratio and MDA level, and improved FFA induced GSIS impairment. CONCLUSION: Elevated circulating FFA levels may contribute to causing the abnormalities of pancreatic islet cell function through active oxidative stress and oxidative stress-sensitive signaling pathway, which may play a key role in the development of impaired insulin secretion seen in obese Type 2 diabetes.
Authors:
X Zhang; Y Bao; L Ke; Y Yu
Related Documents :
4719665 - Neural control of counter-regulatory events during glucopenia in man.
15055475 - Moderate alcohol consumption, glucose metabolism and lipolysis: the effect on adiponect...
10516135 - Acute effect of growth hormone to induce peripheral insulin resistance is independent o...
6341165 - The effect of insulin insufficiency on plasma thyroid hormones and some metabolic const...
16610015 - Treatment of nonalcoholic fatty liver disease.
15983335 - Changing the definition of impaired fasting glucose: impact on the classification of in...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-11-12
Journal Detail:
Title:  Journal of endocrinological investigation     Volume:  33     ISSN:  1720-8386     ISO Abbreviation:  J. Endocrinol. Invest.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-07-14     Completed Date:  2010-10-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7806594     Medline TA:  J Endocrinol Invest     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  388-94     Citation Subset:  IM    
Affiliation:
Division of Endocrinology and Metabolism, Sichuan University, West China Hospital, Cheng Du, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcysteine / pharmacology
Animals
Fat Emulsions, Intravenous / pharmacology
Fatty Acids, Nonesterified / adverse effects,  blood*
Glucose / metabolism
Glucose Tolerance Test
Glutathione / metabolism
Insulin / secretion*
Islets of Langerhans / drug effects*,  secretion
Male
Malondialdehyde / metabolism
Oxidative Stress / drug effects*
Rats
Rats, Sprague-Dawley
Chemical
Reg. No./Substance:
0/Fat Emulsions, Intravenous; 0/Fatty Acids, Nonesterified; 11061-68-0/Insulin; 50-99-7/Glucose; 542-78-9/Malondialdehyde; 616-91-1/Acetylcysteine; 70-18-8/Glutathione

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  EFFECT OF DIETARY GLYCEMIC INDEX ON FOOD INTAKE, ADIPOSITY AND FASTING PLASMA GHRELIN LEVELS IN ANIM...
Next Document:  Zoledronic acid decreases mRNA STEAP expression in prostate cancer cells.